WuXi PharmaTech Expands to Israel; Collaborates on Israeli Investments

WuXi PharmaTech, the China CRO with operations in China and the US, will branch out geographically by opening a representative office in Tel Aviv, Israel. In addition, WuXi will collaborate with Pontifax, an Israeli venture capital firm specializing in life science, to invest in Israeli companies with promising technologies, especially those that could add to WuXi's CRO services. More details.... Stock Symbol: (NYSE: WX) Share this with colleagues: // //